Cargando…
Population Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone in Neonates Undergoing Cardiopulmonary Bypass
Methylprednisolone is used in neonates to modulate cardiopulmonary bypass (CPB)–induced inflammation, but optimal dosing and exposure are unknown. We used plasma methylprednisolone and interleukin (IL)‐6 and IL‐10 concentrations from neonates enrolled in a randomized trial comparing one vs. two dose...
Autores principales: | Hornik, Christoph P., Gonzalez, Daniel, Dumond, Julie, Wu, Huali, Graham, Eric M., Hill, Kevin D., Cohen‐Wolkowiez, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930860/ https://www.ncbi.nlm.nih.gov/pubmed/31646767 http://dx.doi.org/10.1002/psp4.12470 |
Ejemplares similares
-
Using Pharmacokinetic Modeling and Electronic Health Record Data to Predict Clinical and Safety Outcomes after Methylprednisolone Exposure during Cardiopulmonary Bypass in Neonates
por: Foote, Henry P., et al.
Publicado: (2023) -
Estimation of Body Fat Percentage for Clinical Pharmacokinetic Studies in Children
por: Green, Thomas P., et al.
Publicado: (2020) -
A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility
por: Thompson, Elizabeth J., et al.
Publicado: (2023) -
Methylprednisolone Plasma Concentrations During Cardiac Surgery With Cardiopulmonary Bypass in Pediatric Patients
por: van Saet, Annewil, et al.
Publicado: (2021) -
A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass
por: Withington, Davinia E, et al.
Publicado: (2014)